The elemental metal gallium, a substance that has fascinated chemists since its discovery in the late 19th century, has long…
Read More
Automating Descriptive Statistics: A Seven-Step Pathway to Enhanced Data Analysis Efficiency
The initial phase of any robust data analysis project invariably begins with an intimate understanding of the dataset at hand.…
Read More
Can the heart heal itself? New study says it can
A landmark study co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart Center…
Read More
Pouring cold water on ALS progression: novel drug shields neurons from damage
Researchers at the University of Arizona (AZ, USA) have announced a significant advancement in the quest to combat Amyotrophic Lateral…
Read More
Diabetes to MASH: the specimens behind GLP-1’s widening roster
The therapeutic landscape for glucagon-like peptide-1 (GLP-1) receptor agonists has undergone a monumental transformation, extending far beyond its initial applications…
Read More
Virginia Tech Research Challenges Longstanding Models of Neurological Movement Disorders and the Predictive Power of Purkinje Cells
A paradigm-shifting study led by neuroscientists at the Fralin Biomedical Research Institute at VTC has upended decades of conventional wisdom…
Read More
Heidelberg University Physicists Unify Competing Quantum Theories to Explain Impurity Behavior in Fermi Seas
In a landmark advancement for many-body physics, researchers at Heidelberg University’s Institute for Theoretical Physics have successfully reconciled two long-standing,…
Read More
Unlocking Nature’s Pharmacy: Scientists Decipher Bacterial Secrets to Multi-Drug Cancer Therapies
For decades, the intricate molecular dance within bacteria that yields a remarkable array of potent anti-cancer compounds remained an enigma,…
Read More
The Journal at a glance: Q2 2026 highlights from our Editor in Chief
Raleigh, NC — Michelle Itano, Editor-in-Chief of BioTechniques and a distinguished researcher at the University of North Carolina, Chapel Hill,…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…
Read MoreYOU MAY HAVE MISSED
